Identification and Management of ILD in Systemic Sclerosis - Article
Identification and Management of ILD in Systemic Sclerosis - Article
From Lancet Rheumatology, this article reviews evidence-based consensus statements on guidance for the identification and medical management of systemic sclerosis-associated ILD.
What you’ll learn:
- The process used in developing evidence-based consensus statements on SSc-ILD management in relation to six domains: risk factors, screening, diagnosis and severity assessment, treatment initiation and options, disease progression, and treatment escalation
- The results of the expert panel regarding the six domains
- The algorithm developed for the identification and management of SSc-associated ILD
Related Resources
Pulmonary Fibrosis – HCP Resource
Pulmonary Fibrosis and PDE4B – Video
The potential role of PDE4B.
View Resource
SSc-ILD - HCP Resource
Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis ILD - Article
Review the etiology, risk factors, and biomarkers involved in SSc-ILD.
View Resource
SSc-ILD - HCP Resource
Systemic Sclerosis-Associated Interstitial Lung Disease - Slide Deck
Discover the epidemiology, pathogenesis, and diagnosis of SSc-ILD.
View Resource
